APO MYC 180 (Mycophenolic acid delayed-release 180 mg)
Pill imprint APO MYC 180 has been identified as Mycophenolic acid delayed-release 180 mg.
Mycophenolic acid is used in the treatment of rejection prophylaxis; dermatomyositis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 180 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO MYC 180
- Strength:
- 180 mg
- Color:
- Green
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
More about mycophenolic acid
Consumer resources
- Other brands: Myfortic
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
